Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Nurses demand fresh negotiations following NHS consultant pay offer

The 5% pay award for NHS nursing staff in England appears “increasingly inadequate” to keep up with inflation

The Royal College of Nursing (RCN) has expressed “extreme disappointment” that the UK government offered new pay to NHS consultants, while nursing pay deal remain disputed.


RCN General Secretary and Chief Executive Pat Cullen has written to new Health Secretary Victoria Atkins demanding fresh negotiations regarding this year’s pay deal, and requested an urgent meeting to discuss their dispute.

Pat warned that more than 100,000 RCN members in England voted for continued strike action in June, as they feel undervalued.

“The government has now shown it has the political will to negotiate on pay reform for some of the highest earners in the NHS in contrast to our members who received the lowest pay rise in the public sector,” she wrote in the letter.

NHS nursing staff in England was awarded a five per cent pay rise 2023/24, but the union argued that it is not enough to keep up with inflation.

Pat also pointed out that many nurses start and end their career on Agenda for Change Band 5 the lowest band of all regulated professionals in the NHS.

The letter reads, “It is time for nurses and nursing to be treated with the respect they deserve and for nursing pay also to be reformed.

“Nursing is one of the most diverse and female-dominated professions within the public sector, and the injustice of nursing pay is also a gender issue. The greatest pay inequality in the NHS relates to nursing. This must be addressed as a matter of urgency.”

The union mentioned that in previous pay negotiations, the government assured to explore a separate nursing pay spine but that commitment “hasn’t received the urgency it needs.”

“The government should invest less time and attention in its attempt to impose draconian anti-strike laws on nursing staff and get back around the table and discuss nursing pay,” she wrote.

The issue must be resolved as “the NHS requires the stability of a nursing foundation and now more than ever,” she added.

(Image credit: RCN Magazine)

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less